Navigation Links
Atrium Announces a Significant Increase in Revenues and Earnings for the Third Quarter of 2007
Date:11/7/2007

our Health & Nutrition Division in the markets that we serve", stated Pierre Fitzgibbon, Atrium's President and Chief Executive Officer.

Cash flows from operations (before changes in non-cash working capital items) for the third quarter of 2007 were US$11.2 million and were US$7.8 million for the same period last year. In July 2007, Atrium modified its existing revolving credit facility by increasing the authorized amount to US$350 million with the possibility to increase it up to US$425 million under certain conditions. This increases the financing flexibility of the Company and will permit it to continue its acquisition strategy in each of his Divisions.

A Solid Management Team

In addition, during the last quarter, the Company announced the appointment of Dr. Serge Yelle as Executive Vice-President, Health & Nutrition Division. In addition to supervising the operations of certain business units, Dr. Yelle has played a key role over the past few years in the integration of companies acquired by Atrium, including Douglas Laboratories and Mucos.

"Atrium today has reached the stage of a mature corporation and can also count on a highly-skilled and experienced management team demonstrating longstanding expertise and vast know-how. This is in addition to the talent and commitment of our 600 or so employees based in various regions of the world. All these assets have enabled Atrium to become a true world leader in its field in just a few years and they provide us with a solid foundation to pursue our growth and development strategy aggressively", Mr. Fitzgibbon said.

Health & Nutrition Division

Revenues from the Health & Nutrition Division were US$50.9 million for the third quarter ended September 30, 2007, representing an increase of 80.0% over revenues of US$28.3 million for the same period last year. This increase can primarily be explained by the acquisition of Mucos in July 2007. EBITDA was US$15.3 million for the third quarter o
'/>"/>

SOURCE Atrium Innovations Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Atrium Innovations Announces Management Changes
2. Atrium Innovations to Hold 2007 Third Quarter Financial Results Conference Call and Webcast on November 8
3. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
4. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
5. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
6. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
7. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
8. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
9. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
10. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
11. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... 28, 2014 Earlier this month, ... in partnership with the U.S. Air Force on the ... results indicated that this type of fuel made from ... will be important to America’s Eco friendly future. In ... a mandate to become independent of foreign oil over ...
(Date:8/28/2014)... 28, 2014 Whitehouse Laboratories is excited ... partnership with PTI Inspection Systems that will ... of the art leak testing method development and validation ... currently available. As part of this agreement, Whitehouse Labs ... Leak Detection Instrument developed and manufactured by PTI. ...
(Date:8/27/2014)... Rhythm, a biopharmaceutical company developing peptide therapeutics ... in metabolic disorders, announced today that it has filed ... Securities and Exchange Commission (SEC) relating to the proposed ... The number of shares to be offered and the ... determined. Citigroup and Cowen and Company will ...
(Date:8/27/2014)... 27, 2014   MSC , a healthcare performance ... announced the appointment of Mary Beth Loesch ... years of experience preparing companies for rapid growth and ... Vice President of Corporate Development and Healthcare. In that ... , as well as corporate strategy and marketing. Previously, ...
Breaking Biology Technology:Can Small Farmers and a New Seed Based Biofuel “Green” the World? Major Universities and Even the U.S. Air Force Seem to Think So 2Can Small Farmers and a New Seed Based Biofuel “Green” the World? Major Universities and Even the U.S. Air Force Seem to Think So 3Can Small Farmers and a New Seed Based Biofuel “Green” the World? Major Universities and Even the U.S. Air Force Seem to Think So 4Can Small Farmers and a New Seed Based Biofuel “Green” the World? Major Universities and Even the U.S. Air Force Seem to Think So 5Whitehouse Labs Renews Partnership with PTI Inspection Systems 2Whitehouse Labs Renews Partnership with PTI Inspection Systems 3Rhythm Files Registration Statement for Proposed Initial Public Offering 2MSC names Mary Beth Loesch President and CEO 2
... ANGELES, Feb. 18 The Board of Directors wishes to ... 2009 it resolved to file a Form 15 with effect ... the approval of stockholders but in the interests of keeping ... Release.The effect of this filing is to release the company ...
... SAN DIEGO, Feb. 18 Zogenix, Inc. ("Zogenix"), a ... Drug,Administration (FDA) has provided a target date of July ... for Sumavel DosePro (sumatriptan,injection) needle-free delivery system. Zogenix ... treatment of migraine attacks with or without,aura, and the ...
... Inc. (the "Company") (Nasdaq: PDGI ), a ... biotechnology, generic drug and medical device companies, today announced ... Brazil to further enhance its Latin American presence.PharmaNet has ... 2002 with a network of field-based staff in Brazil, ...
Cached Biology Technology:EESTECH Inc - Release From SEC Filing 2EESTECH Inc - Release From SEC Filing 3EESTECH Inc - Release From SEC Filing 4Zogenix Reports FDA Provides New PDUFA Date for Sumavel(TM) DosePro(TM) 2PharmaNet Development Group, Inc. Expands Latin America Operations with Opening of Brazil Office 2PharmaNet Development Group, Inc. Expands Latin America Operations with Opening of Brazil Office 3PharmaNet Development Group, Inc. Expands Latin America Operations with Opening of Brazil Office 4PharmaNet Development Group, Inc. Expands Latin America Operations with Opening of Brazil Office 5
(Date:8/28/2014)... 28, 2014) Researchers at the University of Minnesota ... dystrophy (FSHD) to be used for muscle regeneration research ... therapies for FSHD. , The research is published in ... . , There is no treatment for FSHD, which ... type of muscular dystrophy. FSHD is an unusual genetic ...
(Date:8/28/2014)... compounds that could positively impact the global ... possible, thanks to researchers in Penn State,s ... suppository made from the seaweed-derived food ingredient ... Tenofovir provides a woman-initiated, drug-delivery vehicle that ... transmitted infections during unprotected heterosexual intercourse, the ...
(Date:8/28/2014)... roads will be built worldwide by 2050. Many of ... they bring an influx of destructive loggers, hunters and ... created a ,global roadmap, for prioritising road building across ... of development and environmental protection. , The map has ... importance of ecosystems and a ,road-benefits, layer that estimates ...
Breaking Biology News(10 mins):UMN researchers find animal model for understudied type of muscular dystrophy 2Sensory-tested drug-delivery vehicle could limit spread of HIV, AIDS 2Sensory-tested drug-delivery vehicle could limit spread of HIV, AIDS 3Study shows where on the planet new roads should and should not go 2Study shows where on the planet new roads should and should not go 3
... of Post-Traumatic Stress Disorder (PTSD) is unpredictable. Because it ... is difficult to identify preventative or causative factors. Scientists ... to study the disorder, but that means they can,t ... trauma. Now, through a combination of genetic ...
... 13, 2013) For consumers of the typical Western dietladen with ... to believe that there is such a thing as an ... Charles Zuker, PhD, and colleagues at Columbia University Medical Center ... (think seawater levels, not potato chips), the first step in ...
... 13, 2013) Whitehead Institute researchers have identified a ... for the generation of undesirable white fat cells. When ... to accumulate lipid droplets or mature from their precursors. ... iswhat it takes to make fat cells," says Whitehead ...
Cached Biology News:Gene associated with high anxiety can have protective effect on the battlefield 2Gene associated with high anxiety can have protective effect on the battlefield 3Scientists discover how animals taste, and avoid, high salt concentrations 2Scientists discover how animals taste, and avoid, high salt concentrations 3Long noncoding RNAs control development of fat cells 2
... different human fetal normal tissues are ... upon request. Customers can choose ... set, and pay 70% of the ... P Set products are for research ...
... delivery of buffer and fixative results ... version. In Vivo Manual Perfusion Fixation ... of buffer and fixative results in ... use and clean--Complete system with everything ...
Mouse IL-31 RA Biotinylated Affinity Purified PAb...
... plus assay system offers the ... Designed for batch-processing systems, Long ... density microplates such as 384-well ... Convenient storage conditions ( 2 ...
Biology Products: